Back to search

Article

Manipulating the Gut Microbiome to Alleviate Steatotic Liver Disease: Current Progress and Challenges

2024-05-31

Abstract excerpt

The prevalence of metabolic-dysfunction-associated steatotic liver disease (MASLD) is alarmingly high; it is estimated to affect up to a quarter of the global population, making it the most common liver disorder worldwide. MASLD is characterized by excessive hepatic fat accumulation and is commonly associated with comorbidities such as obesity, dyslipidemia, and insulin resistance; however, it can also manifest in...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5a2d9996-9fc9-5e5c-a629-0fb812c8e1b0
DOI
10.1016/j.eng.2024.03.019
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Manipulating the Gut Microbiome to Alleviate Steatotic Liver Disease: Current Progress and ChallengesDOI 10.1016/j.eng.2024.03.019
Role of the Gut Microbiome in Metabolic Dysfunction-Associated Steatotic Liver DiseaseSemantic proximity
NAFLD/MASLD and the Gut–Liver Axis: From Pathogenesis to Treatment OptionsSemantic proximity
Interplay between gut microbiome, host genetic and epigenetic modifications in MASLD and MASLD-related hepatocellular carcinomaSemantic proximity
Exploring the Role of Probiotics, Prebiotics, and Synbiotics in the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease—A Scoping ReviewSemantic proximity
The role of microbiota in nonalcoholic fatty liver disease: mechanism of action and treatment strategySemantic proximity
Non-alcoholic fatty liver disease: molecular and cellular interplays of the lipid metabolism in a steatotic liverSemantic proximity
The gut microbiome and gut-liver axis in NAFLDSemantic proximity
Current Concepts, Opportunities, and Challenges of Gut Microbiome-Based Personalized Medicine in Nonalcoholic Fatty Liver DiseaseSemantic proximity
Fatty Liver Disease and Gut Microbiota: A Comprehensive UpdateSemantic proximity
The Role of the Intestinal Microbiota in Nonalcoholic SteatohepatitisSemantic proximity
Gut microbiota and related metabolites in the pathogenesis of nonalcoholic steatohepatitis and its resolution after bariatric surgerySemantic proximity
Gut Microbiota-Related Cellular and Molecular Mechanisms in the Progression of Nonalcoholic Fatty Liver DiseaseSemantic proximity
Select a neighboring publication to make it the new centre.